Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL9P29 encodes a pseudogene, specifically "Ribosomal protein L9 pseudogene 29". Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they may arise from gene duplication or retrotransposition. RPL9P29 is related to RPL9, which encodes a component of the 60S subunit of ribosomes, but RPL9P29 itself does not produce a functional protein and has no known biological, therapeutic, or disease role[5]. There are many processed pseudogenes of ribosomal proteins throughout the human genome[1][3]. RPL9P29 is a non-functional pseudogene, not a therapeutic or druggable target[5]. There are no known aliases, disease roles, functions, or drug interactions for RPL9P29[5]. If searching for a ribosomal protein L9 functional target, the appropriate gene is RPL9 (Ribosomal protein L9), not this pseudogene[1][3][5].
None; not targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L9 pseudogene 29 (RPL9P29).